ALNYLAM PHARMACEUTICALS, INC. (ALKS) has 205 open-market insider trades by 30 insiders since 2007. Over the last six months insiders net sold $2.9M. The most active filer is Richard F. Pops, CEO & Director.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Science Three Ltd Elan | 10% | — | 1 | $381.6M | 2012-03-13 |
| Richard F. Pops | CEODir | — | 39 | $83.7M | 2026-02-05 |
| Michael J. Landine | VP | — | 26 | $16.3M | 2024-02-23 |
| Shane Cooke | Dir | — | 20 | $12.8M | 2026-05-21 |
| James M. Frates | CFOVP | — | 8 | $8.4M | 2020-05-14 |
| Elliot Ehrich | CMOVP | — | 19 | $8.4M | 2017-05-28 |
| Iain Michael Brown | CFOVP | — | 6 | $4.2M | 2025-02-26 |
| Kathryn L. Biberstein | CLOVP | — | 7 | $4.0M | 2026-09-03 |
| Mark Stejbach | VP | — | 5 | $2.5M | 2018-03-03 |
| Paul J. Mitchell | Dir | — | 26 | $2.4M | 2021-05-20 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| David Joseph Gaffin | CLO & VP | Sell | $83K | 2026-10-02 |
| Kathryn L. Biberstein | CLO & VP | Sell | $98K | 2026-09-03 |
| Craig C. Hopkinson | VP | Sell | $423K | 2026-09-01 |
| Christian Todd Nichols | CCO & VP | Sell | $373K | 2026-08-17 |
| David Joseph Gaffin | CLO & VP | Sell | $99K | 2026-08-03 |
| Nancy Lynn Snyderman M.D. | Director | Sell | $2.2M |
Companies that share insiders with ALKS, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| 2026-08-03 |
| Craig C. Hopkinson | VP | Sell | $437K | 2026-08-03 |
| David Joseph Gaffin | CLO & VP | Sell | $110K | 2026-07-06 |
| Craig C. Hopkinson | VP | Sell | $464K | 2026-07-01 |
| Christopher I. Wright | Director | Sell | $90K | 2026-06-12 |
| David Joseph Gaffin | CLO & VP | Sell | $88K | 2026-06-04 |
| Craig C. Hopkinson | VP | Sell | $375K | 2026-06-01 |
| Samuel Joseph Parisi | VP | Sell | $687K | 2026-05-29 |
| David Joseph Gaffin | CLO & VP | Sell | $68K | 2026-05-04 |
| Craig C. Hopkinson | VP | Sell | $301K | 2026-05-01 |